適時開示情報
- 2025/04/09
- StemRIM Announces Setting the Record Date and Holding for Extraordinary General Meeting of Shareholders and Reduction of Capital Stock
- 2025/04/03
- StemRIM Announces Patent Registration (China) for the Use of the HMGB1 Fragment Peptide, Redasemtide
TD-net(適時開示情報閲覧サービス)にて開示された情報を掲載しております。